Chemotherapy enrichment for CD133 expressing cells with deficient THBS2 expression, which facilitates the promotion of cancer stemness properties in hepatocellular carcinoma (HCC) cells through extracellular matrix remodeling, is described. The gene discussed is THBS2; the disease is hepatocellular carcinoma.